Testa Analytical has published a study that investigates parameters that can be tweaked to improve dynamic light scattering measurement quality when analyzing monomeric and aggregated monoclonal antibodies.

CEPI, the Coalition for Epidemic Preparedness Innovations, today announced a ninth worldwide collaboration to develop a COVID-19 vaccine. CEPI will invest an initial US$3.5 million in a partnering agreement with Clover Biopharmaceuticals AUS Pty Ltd.

INOVIO recently announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800 is fully enrolled with all 40 healthy volunteers receiving their first dose, with interim immune responses and safety results expected in late June.

Hardy Diagnostics has announced FDA EUA approval on April 24th for a new in vitro diagnostic medical device: Anti-SARS-CoV-2 Rapid Test.

TTP and ODx are collaborating to reduce the turnaround time for the assessment of suspected UTIs, reduce the use of antibiotics and provider faster access to optimal antimicrobial therapy.

ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.

ImmunoCAP Specific IgE Stinging Insect Allergen Components have been cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use.

Leinco Technologies, Inc. has announced an agreement with Vanderbilt University Medical Center to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test.

Digital Science's ReadCube has announced the launch of an unprecedented new initiative to facilitate access to literature relevant to COVID-19 research.